Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing

Go back to Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
StemCells, Inc. (NASDAQ: TEM) Delayed: 48.61 +0.76 (1.59%)
Previous Close $47.85    52 Week High $0.45 
Open $47.00    52 Week Low $0.37 
Day High $49.85    P/E N/A 
Day Low $46.68    EPS $-0.31 
Volume 5,325,349